Wyeth's Tygacil approved for bacterial pneumonia in US
This article was originally published in Scrip
Executive Summary
The FDA has approved Wyeth's antibiotic Tygacil (tigecycline) for the treatment of community-acquired bacterial pneumonia (CABP) in adults.